By Ludwig Burger and Bhanvi Satija FRANKFURT (Reuters) -Swiss drugmaker Novartis on Thursday forecast sales growth of 5% to 6 ...

FRANKFURT (Reuters) -Swiss drugmaker Novartis on Thursday projected currency-adjusted sales growth of 5% to 6% until 2030, ...

Novartis AG boosted its sales targets for two key cancer drugs, underscoring confidence in its oncology pipeline.

Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A Birmingham grandmother said she can live her life as "if I haven't got cancer", after the breakthrough drug she is taking ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...

The company, which had no revenue last year and $5.1 million in sales for the first nine months of this year with widening ...

DENVER -- Planned treatment "holidays" can help lessen the toxicity burden of tyrosine kinase inhibitors (TKIs) for selected ...